COVID-19 microscopic image

Research to

Combat Emerging Infectious Diseases

Soldier Health. World Health.

Interactive world map with highlighted regions

Who We Are

The Emerging Infectious Diseases Branch (EIDB) at the Walter Reed Army Institute of Research leads efforts to anticipate, prepare for and rapidly respond to infectious disease threats through an accelerated, iterative cycle of countermeasure development — from conception through human clinical trials.

Learn More

Dr. Kayvon Modjarrad and Dr. Gordon Joyce discuss EIDB's strategic approach to the COVID-19 vaccine, SpFN, developed at the Walter Reed Army Institute of Research.

Spotlight

SpFN First Dose

A unique vaccine to protect against COVID-19 begins Phase 1 clinical testing in early April at the at the Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center. Scientists developed a nanoparticle vaccine based on a ferritin platform that offers a flexible approach to target multiple variants of SARS-COV-2 and potentially other coronaviruses as well